Wedbush Upgrades Thoratec To Neutral

According to Wedbush, Thoratec THOR is upgraded to Neutral. Wedbush said that THOR reported Q2:2011 revenues of $111.2 million and EPS of $0.44, well above estimates of $103.7 million and $0.35, and consensus of $104.4 million and $0.35. “Raising fair value to $33 from $27 and upgrading to NEUTRAL from UNDERPERFORM.” Thoratec closed yesterday at $33.85.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorUpgradesPrice TargetAnalyst RatingsHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!